key: cord-0905334-cgz1980o
authors: Marcault, Clémence; Fodil, Sofiane; Dupont, Thibault; Darmon, Michael; Azoulay, Elie
title: In response to the letter of Montagud‐Marrahi et al.
date: 2020-06-08
journal: Am J Transplant
DOI: 10.1111/ajt.16126
sha: 920e78931123b7d27bed2b232b3732b3561c3dd0
doc_id: 905334
cord_uid: cgz1980o

We read with interest the correspondence from Montagud‐Marrahi et al. putting forward that solid organ transplant (SOT) recipients are not at higher risk of severe COVID‐19 infection despite their immunosuppression and the mild or atypical nature of their symptoms in their Spanish cohort. In the recent literature, this population achieves a mortality rate between 20% and 52% when they become critically ill. Moreover, as innate immunity is altered by the infection, decreased doses of immunosuppressive drugs should be considered.

recent literature, this population achieves a mortality rate between 20% and 52% when they become critically ill 2,3(p) . Moreover, as innate immunity is altered by the infection, decreased doses of immunosuppressive drugs should be considered 4, 5 .

At the Saint-Louis hospital, Paris, among the 106 critically ill COVID patients, we identified 10 consecutive adult SOT recipients (9 kidney and 1 heart, age 57 (range, 49 to 72 years, 70% male) who tested positive for COVID-19 between March 7 and April 10, 2020. Median time from organ transplantation was 50 months (75-80). Main comorbidities included hypertension (100%) and diabetes (50%). All patients were admitted with acute hypoxemic respiratory failure, 90% with asthenia, 70% with fever, and 40% with In conclusion, SOT patients form a specific group of COVID-19 immunocompromised patients with more profound lymphocytopenia, prevalence of AKI and need for RRT. Despite immunosuppression and high inflammation, survival and renal recovery are substantial for ICU patients 3,5 but higher than average COVID-19 patients 4 .

The authors of this manuscript have no conflicts to disclose as described by the American Journal of Transplantation.

This article is protected by copyright. All rights reserved Solid organ transplant recipients with COVID-19 present with lower total lymphocyte count than COVID-

Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single centre cohort of kidney recipients

Outcomes of kidney transplant recipients admitted to the intensive care unit: a retrospective study of 200 patients

COVID-19 in solid organ transplant recipients: Initial report from the US epicenter

Early experience with COVID-19 in kidney transplantation

Covid-19 and Kidney Transplantation

Accepted Article